When a medication prescribed to help you ends up making you worse, the consequences reach far beyond a bad reaction. Serious injuries, permanent health complications, and the financial pressure of ongoing medical care can overturn your life in ways you never anticipated. Sweeney Merrigan has represented Massachusetts victims in complex personal injury matters for three generations, and our team understands what it takes to pursue accountability when a dangerous drug causes real harm. If you are searching for a Lawrence defective drug lawyer, our attorneys are prepared to evaluate your case and fight for the compensation you deserve.
Defective drug cases involve some of the most sophisticated legal and medical questions in personal injury law. Pharmaceutical companies employ large legal teams and spend considerable resources defending against these claims. Our firm has the trial experience, the resources, and the determination to take on powerful defendants, and we pursue results that reflect the full extent of your losses.
Legal Representation for Defective Drug Cases in Lawrence
Lawrence is a densely populated city in Essex County, Massachusetts, with a large and diverse community that relies on prescription and over-the-counter medications for chronic conditions, acute illnesses, and ongoing health management. Residents treated at Lawrence General Hospital and facilities throughout the Merrimack Valley deserve to know that when a drug causes harm, the law provides a path to accountability.
Massachusetts product liability law gives injured victims the legal tools to seek accountability from the parties responsible for putting a dangerous drug on the market. Our attorneys handle defective drug cases in Lawrence, across Essex County, and throughout the Commonwealth. We bring the full weight of our litigation experience to every client we represent, and we do not accept early settlements that fail to reflect what our clients have actually been through.
The size and complexity of a defective drug claim should not prevent you from pursuing it. Our firm advances the costs of litigation, meaning you pay nothing out of pocket while your case is being built. We work on a contingency fee basis, so our attorneys are compensated only when you recover.
What Is a Defective Drug
A drug becomes legally defective when something about it makes it unreasonably dangerous to the people who use it as intended. Applying that standard requires careful analysis of how the drug was designed, produced, and distributed, and of how it reached patients and physicians.
Not every negative reaction to a medication means the drug was defective. Some side effects are well-documented, disclosed, and accepted risks of treatment. A defective drug case arises when the harm a patient suffers exceeds what was reasonably disclosed, or when the product itself is flawed in a way that causes injury that should not have occurred.
Under Massachusetts law, sellers and manufacturers carry an implied promise that their products are fit for intended use. Massachusetts General Laws Chapter 106, Section 2-314 establishes the implied warranty of merchantability, which courts have applied in product liability cases involving dangerous drugs. When a pharmaceutical product fails to meet that standard, injured patients may have grounds to pursue a claim.
When a Medication Causes Harm Instead of Healing
Most people take medications trusting that the product they are given has been properly developed, carefully manufactured, and honestly labeled. That trust is reasonable, and when it is violated, the results can be devastating.
A medication can cause harm in several distinct ways. It may have been designed with a formulation that creates risks outweighing its benefits, when a safer alternative existed at the time of approval. It may have been contaminated or incorrectly dosed during manufacturing, producing a product that differs from what was intended. Or the drug may have carried known risks that were never communicated to prescribers or patients, leaving them without the information needed to make an informed decision.
Each scenario involves a different legal theory, a different set of defendants, and a different evidentiary burden. Identifying which type of defect applies to your situation is one of the first steps our attorneys take when evaluating a claim.
Types of Defective Drug Claims
Defective drug claims fall into three primary legal categories. Each addresses a different point in the chain from drug development to patient use, and each requires its own analysis of what went wrong and who bears responsibility.
Design Defects
A design defect exists when the drug’s formulation itself is the source of the problem. The product was manufactured exactly as intended, but the intention was flawed. If the chemical composition, dosing regimen, or interaction profile of the drug created unreasonable risks that a safer, equally effective alternative could have avoided, the product’s design may be defective.
Design defect claims are among the most challenging in pharmaceutical litigation. They require scientific and medical expert testimony to establish that a safer design was both feasible and available at the time the drug was brought to market. These claims also tend to affect large numbers of patients, since every unit of the drug carries the same flaw.
When a design defect causes widespread harm, cases are sometimes consolidated into mass tort litigation. This requires attorneys who understand both individual client representation and the broader litigation landscape, something our team has navigated directly.
Manufacturing Defects
A manufacturing defect arises when the drug’s design is sound, but something goes wrong during production. This type of defect typically affects a specific batch or lot of medication rather than every unit of the product. Contamination, mislabeling, incorrect ingredient concentrations, improper storage conditions, and sterility failures are all examples of manufacturing defects that have led to serious patient injuries.
Manufacturing defect cases require close examination of production records, quality control documentation, and regulatory inspection histories. The U.S. Food and Drug Administration oversees pharmaceutical manufacturing standards through current Good Manufacturing Practice regulations, and violations of those standards can be significant evidence in a claim.
Because manufacturing defects often occur in clusters, determining whether others were harmed by the same batch or lot number is often an important step. Our attorneys know how to request and analyze the production and regulatory records that reveal where and how the defect occurred.
Failure to Warn
Failure-to-warn claims address situations in which the drug itself may have been properly designed and manufactured, but prescribers and patients were not given adequate information about known risks. Drug manufacturers have a legal obligation to disclose material risks to physicians, pharmacists, and patients. When that obligation is not met, and a patient suffers harm from a known but undisclosed risk, a failure-to-warn claim may apply.
These claims are particu larly common in cases involving serious side effects that emerged in clinical trials or post-market surveillance but were not prominently included in labeling or prescribing information. The FDA requires manufacturers to update their labeling when new safety information becomes available. When companies delay updates or downplay the severity of known risks, the legal exposure can be significant.
The FDA’s guidance on finding and learning about side effects and adverse reactions makes clear that patients and providers are entitled to accurate and current safety information. When that information is withheld or minimized, the legal responsibility falls on those who controlled it.
Common Injuries Caused by Dangerous Drugs
The injuries that result from defective or dangerous drugs span a wide spectrum. Some cause acute harm that resolves with treatment. Many cause conditions that are permanent, progressive, or life-altering, affecting a person for years or decades.
Short-Term and Long-Term Health Effects
Short-term injuries from defective drugs can include severe allergic reactions, acute organ stress, dangerous cardiac events, neurological episodes, and acute toxicity from contaminated or incorrectly dosed medications. These injuries may be treatable with prompt and aggressive medical intervention, but they can also mark the beginning of far more serious complications.
The long-term health effects are where the full weight of a defective drug injury becomes most apparent. Patients have suffered permanent liver and kidney damage from drugs that failed to disclose the extent of organ toxicity. Others have experienced lasting neurological conditions, including movement disorders, cognitive impairment, and nerve damage that emerged months or years after using a medication.
Cardiovascular damage from undisclosed cardiac risks has left patients with chronic heart conditions requiring lifelong management. Cancer diagnoses have been linked to contaminated drugs, including recalls involving nitrosamine contamination in blood pressure and diabetes medications. For Lawrence residents managing chronic conditions with daily prescription regimens, these risks are not abstract. They reflect the real consequences of pharmaceutical failures in this community.
The financial burden of ongoing specialist care, physical therapy, and reduced earning capacity compounds the harm significantly. When a defective drug sets off a chain of medical events that alters a person’s life, the damages at stake in litigation must reflect that full trajectory.
Who May Be Liable in a Defective Drug Case
Liability in defective drug litigation does not always rest with a single party. Depending on the nature of the defect and how the drug moved through the supply chain before reaching the patient, multiple defendants may share responsibility.
Pharmaceutical Companies
Pharmaceutical manufacturers are the primary defendants in most defective drug cases. They are responsible for the drug’s design, the conduct of clinical trials, the integrity of the manufacturing process, and the accuracy of warnings and labeling. When any of those responsibilities are not met, and a patient is injured as a result, the manufacturer is generally the first party whose liability must be analyzed.
Large pharmaceutical companies often mount aggressive defenses. They may argue that the plaintiff assumed known risks, that the prescribing physician was adequately warned even if the patient was not, or that the injury was caused by factors unrelated to the drug. Anticipating and countering those arguments requires deep familiarity with pharmaceutical litigation strategy and with attorneys prepared to take a case to trial.
Massachusetts product liability doctrine, as reflected in the Massachusetts Products Liability Claims guidance published by the Commonwealth, establishes that a manufacturer who places a defective product into the stream of commerce can be held responsible for resulting harm, regardless of the level of care taken during production. This strict liability framework is an important tool for drug injury victims in Lawrence and across the state.
Healthcare Providers and Pharmacies
While pharmaceutical companies bear the primary liability in most cases, healthcare providers and pharmacies can also be responsible under certain circumstances. A physician who prescribes a drug inconsistently with its approved use, fails to account for a patient’s known risk factors, or does not communicate material warnings may bear independent liability for the resulting harm.
Pharmacies and dispensing entities can be liable when they fill a prescription incorrectly, dispense the wrong medication or dosage, or fail to flag dangerous drug interactions. When harm results from multiple points of failure, naming the appropriate defendants from the outset is critical. Our attorneys conduct thorough investigations to identify every party whose negligence or breach of warranty contributed to the injury.
When a Drug May Be Recalled by the FDA
A drug recall does not always mean a company voluntarily removed a product from the market. The FDA classifies recalls and can take enforcement action when a drug poses a risk to public health. Understanding how recalls work is an important context for anyone harmed by a medication that was later pulled from use.
According to the FDA’s guidance, recalls are classified into three categories based on risk level. Class I recalls involve products that could cause serious adverse health consequences or death. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences. Class III recalls involve products that violate FDA regulations but are unlikely to pose an adverse health risk.
A Class I recall is the strongest signal that a drug posed a genuine danger to patients who used it. When a drug you took has been recalled, particularly under a Class I classification, that regulatory record becomes meaningful evidence in a civil claim.
A recall alone does not automatically establish liability. The injured person must still connect the recalled drug to their specific injury, demonstrate the nature of the defect, and show that the defect caused the harm they suffered. However, a recall creates a documented record that regulators found serious enough problems to warrant the drug’s removal, and that record can carry substantial weight in litigation.
Can You Sue for Injuries Caused by a Defective Drug
Victims injured by a defective drug may have the legal right to pursue a civil claim for compensation, though whether a viable case exists depends on the specific circumstances of each situation. Massachusetts law provides avenues for drug injury victims to seek accountability, but the analysis is fact-intensive and must be handled carefully.
Legal Grounds for Filing a Claim
In Massachusetts, defective drug claims are most commonly pursued under product liability theories, including breach of the implied warranty of merchantability under Massachusetts General Laws Chapter 106, Section 2-314, negligence, and strict liability. In practice, attorneys often pursue multiple theories simultaneously to ensure the strongest possible case is presented.
A breach of warranty claim focuses on whether the drug was fit for its ordinary intended purpose. A negligence claim examines whether the manufacturer, distributor, or healthcare provider acted with reasonable care at each stage of the drug’s development and delivery. A strict liability claim allows an injured person to hold a manufacturer responsible for a defective product without proving the company was careless, only that the product was defective and that the defect caused the injury.
Massachusetts law also imposes a statute of limitations governing how long an injured person has to file a claim. In most personal injury cases in Massachusetts, that period is three years from the date of injury or discovery of the injury, though specific facts can affect this timeline. Failing to file within that window can permanently bar recovery, which is one reason why speaking with an attorney promptly after a drug injury is strongly advisable.
How Liability Is Proven in Defective Drug Cases
Proving liability in a defective drug case is a rigorous process. These cases rarely turn on a single piece of evidence. They require assembling a comprehensive factual and scientific record that connects the defendant’s conduct to the plaintiff’s injury.
Evidence and Legal Standards
The core categories of evidence in defective drug litigation include medical records documenting the injury and its treatment, pharmacy records showing which drug was dispensed, and prescribing records reflecting the physician’s clinical decision-making. These materials establish the timeline and the connection between drug use and harm.
Expert testimony is central to nearly every defective drug case. Medical experts explain the mechanism by which the drug caused the plaintiff’s injury. Pharmacological experts analyze the drug’s design, formulation, and known risk profile. Regulatory experts address whether the manufacturer met or violated FDA standards in its development and labeling practices.
Regulatory records, including FDA inspection reports, adverse event reports submitted through the FDA’s MedWatch system, internal company communications produced in discovery, and clinical trial data, can be critical to establishing what the manufacturer knew and when. The legal standard in Massachusetts product liability cases requires the plaintiff to prove their claim by a preponderance of the evidence. Our attorneys build cases designed to meet that standard with precision, drawing on qualified expert witnesses and thorough documentary evidence at every stage.
Compensation Available in Defective Drug Claims
The damages available in a successful defective drug claim are intended to make the injured person whole for the losses the defective product caused. These claims can involve substantial compensation when the injuries are serious and the impact on the victim’s life is significant.
Medical Costs, Lost Income, and Long-Term Damages
Compensation in defective drug cases typically falls into two broad categories. Economic damages cover financial losses that can be calculated with reasonable specificity. Non-economic damages address the personal and human toll of the injury.
Economic damages include all past and future medical expenses related to the injury, including hospitalization, surgery, specialist care, prescription medications, physical therapy, rehabilitation, and any assistive devices or home modifications required. They also include lost wages for time missed from work and lost earning capacity when the injury affects the plaintiff’s ability to work at the same level going forward.
Non-economic damages compensate for pain and suffering, emotional distress, loss of enjoyment of life, and disruption to personal relationships and daily functioning. Compensatory damages are designed to restore the injured person to the position they would have been in had the harm not occurred. In a serious drug injury case, that standard encompasses a wide range of losses.
In cases where the defendant’s conduct is particularly egregious, such as a company that concealed known safety risks to protect market share, Massachusetts courts may award punitive damages above and beyond compensatory damages to punish wrongful conduct and deter similar behavior in the future.
What to Do After an Injury from a Dangerous Drug
Taking the right steps after a drug injury matters both for your health and for the strength of any legal claim you may have. The actions you take in the days and weeks following an injury can significantly affect what evidence is available and how clearly the connection between the drug and your harm can be established. If you or someone you love has been harmed by a medication in Lawrence or anywhere in Essex County, these steps apply immediately:
- Stop Taking the Medication: Contact your prescribing physician right away and do not dispose of any remaining pills, packaging, or documentation, as the lot number and packaging insert may be critical to identifying the source of the defect.
- Document the Adverse Reaction: Ensure your physician records it in your medical file and reports it to the FDA’s MedWatch system as soon as possible. That contemporaneous record can be difficult for defense teams to challenge later.
- Seek All Necessary Medical Care: Follow all recommended treatments. Gaps in care can be used by defense attorneys to undermine your claim and reduce the compensation you may be entitled to recover.
- Preserve Every Related Document: Keep prescriptions, pharmacy receipts, and any correspondence from the drug manufacturer or their representatives. Do not discard anything before speaking with an attorney.
- Contact a Qualified Attorney: Evidence and regulatory records must be secured before they become unavailable, and early legal involvement helps protect against statute-of-limitations issues.
Challenges in Defective Drug Litigation
Defective drug cases are not straightforward. Even when the facts strongly support a plaintiff’s claim, these cases present structural challenges that require attorneys who understand both the science and the law.
Complex Medical and Legal Issues
The connection between a drug and a specific injury is rarely self-evident. Defense teams routinely argue that the plaintiff’s condition was caused by an underlying disease, a different medication, or lifestyle factors unrelated to the drug at issue. Rebutting those arguments requires qualified medical experts who can credibly address causation and withstand cross-examination.
Pharmaceutical litigation also involves extensive pre-trial discovery. Obtaining internal company documents, clinical trial records, and regulatory correspondence can require court intervention and significant time. Defense attorneys for large pharmaceutical companies are skilled at limiting discovery and challenging expert qualifications, and plaintiffs’ counsel must be equally skilled at protecting the evidentiary record.
When a drug has harmed large numbers of patients, cases are sometimes coordinated into multidistrict litigation or consolidated class actions. Our firm treats every client as a priority, regardless of how broadly the litigation extends. Individual circumstances are always fully represented, even within a larger case structure spanning thousands of claimants.
How Sweeney Merrigan Handles Defective Drug Cases
Sweeney Merrigan approaches defective drug litigation the same way we approach every serious personal injury matter: with thorough preparation, qualified expert support, and an unwillingness to accept less than our clients deserve.
From the moment we take a case, our attorneys begin building the evidentiary foundation that serious drug litigation requires. We retain medical and pharmacological experts with credentials specific to the drug and injury at issue. We pursue full discovery of the defendant’s internal records, clinical data, and regulatory history. We develop a clear narrative of causation that connects the defendant’s conduct to the client’s harm in terms a jury can understand and evaluate.
Our results reflect that approach. Our firm has recovered over $500 million for Massachusetts clients, including a $7 million recovery in a traumatic brain injury and products liability matter, a $9 million recovery in a workplace products liability case, and a $2.6 million confidential settlement in a pharmaceutical drug case. Those outcomes were not achieved by settling early or avoiding hard fights. They came from building cases that were ready for trial and from opponents who understood we would take them there.
Hon. Thomas T. Merrigan (Ret.), a former trial judge recognized as Trial Judge of the Year, is a partner at our firm. Our attorneys have been recognized in Best Lawyers in America and Best Lawyers: Ones to Watch. That depth of judicial and litigation experience carries real weight in pharmaceutical cases, where credibility with courts, opposing counsel, and expert witnesses influences outcomes at every stage of the process.
We also understand that our clients are managing serious health consequences while their cases are being litigated. We communicate clearly, keep clients informed at every stage, and treat every person we represent with the full attention and dedication they deserve. For Lawrence residents and families across Essex County, our commitment does not change based on the size or complexity of the case.
When To Contact Sweeney Merrigan About A Defective Drug Case
If you or someone you love suffered serious complications after taking a prescription or over-the-counter medication, do not wait to learn about your legal options. Dangerous drug cases are complex, and pharmaceutical companies often move quickly to limit their liability once injuries are reported. Speaking with an experienced attorney early can help preserve evidence and protect your right to pursue compensation.
Sweeney Merrigan represents victims in Lawrence, throughout Essex County, and across Massachusetts who have been harmed by defective and dangerous medications. We offer free consultations, and there is no fee unless we recover compensation for you.
Call (617) 391-9001 today to speak directly with a Lawrence defective drug lawyer about your case and learn how our team can help you pursue the accountability and financial recovery you deserve.
